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1. Introduction
The pioneering landmark, established by Takahashi and Yamanaka (Takahashi et al., 2007;
Takahashi and Yamanaka, 2006) in reprogramming somatic cells into induced pluripotent
stem (iPS) cells using the four transcriptional factors of Oct4, Sox2, Klf4, and c-Myc, represents
one of the most important paradigm shifts in current stem cell biology. This unprecedented
discovery could potentially revolutionize regenerative medicine, cell-based therapy and
personalized medicine. Despite recent great advancement in cell reprogramming, there are
still considerable technical challenges to circumvent restrictions of applications of reprogram‐
ming technology (Kawamura et al., 2009; Saha and Jaenisch, 2009). The utilization of over-
expressed transcriptional factors, which of many play oncogenic roles, during somatic
reprogramming posts the risk of malignant transformation, thus, limiting its clinical applica‐
tions. Moreover, the reprogramming process using these factors is still inefficient in some of
cell types, and is not always successful in other kinds of cells (Kawamura et al., 2009; Marion
et al., 2009; Menendez et al., 2012). Therefore, the underlying mechanisms for signaling control
of these factors still need to be further explored.
Somatic cell reprogramming is a complicated cellular process that is controlled by many
signaling networks. Accumulated evidence indicated that stemness transition can be detected
in some tumor cells following the introduction of relevant signal stimulation, and cancer cells
or differentiated cells can be changed into stem cell-like cells that go through less-differentiated
stages (Chen et al., 2008; Fodde and Brabletz, 2007; Huang et al., 2009; Liu et al., 2009a).
© 2013 Cheung et al.; licensee InTech. This is an open access article distributed under the terms of the
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However, stemness transition may not lead to a full reprogramming of treated cells, which is
determined by the delicate controls of signaling network activities in living cells. Interestingly,
stemness transition may accompany epithelial-mesenchymal transition (EMT) events in cancer
cells, and both programs are closely linked to the core stem cell gene network activities. Not
surprisingly, multiple signaling pathways have been reported to be involved in EMT events
and generation of stem cell-like cells. Wnt/β-catenin and TGF-β signaling are two potent
inducers of EMT during embryonic development and cancer progression (Li et al., 2010; Mani
et al., 2008; Morel et al., 2008; Scheel et al., 2011). Other involved pathways in these cellular
activities may include BMP/Activin/Nodal, Notch, Hedgehog, Fibroblast growth factor
signaling, and others (Chen et al., 2008; Huang et al., 2009; Kang and Massague, 2004;
Natalwala et al., 2008; Thiery, 2002, 2003; Wu and Zhou, 2008).
The Wnt/β-catenin signaling pathway, highly conserved among various species and composed
of a large family of proteins that control many biological properties (Fodde and Brabletz,
2007; Kikuchi et al., 2009; ten Berge et al., 2008b), may play a central role in the control of
reprogramming and stemness process. This pathway includes more than two hundred genes
and plays a critical role in modulating the delicate balance among stemness, proliferation, and
differentiation in certain stem cell niches and tumor cells (Gu et al., 2010; Katoh, 2007; Lowry
et al., 2005; Reya and Clevers, 2005). The established evidence reveals that various levels of
Wnt/β-catenin signaling are likely to contribute to distinct cellular activities such as stemness
transition, differentiation, carcinogenesis, and the EMT program. Therefore, the cellular
activities and fate decisions are determined by this signaling activity in both dosage-dependent
and tissue-dependent fashions (Anton et al., 2007; Kikuchi et al., 2009; Lluis et al., 2008; Reya
and Clevers, 2005; Slack et al., 1995; Tapia and Scholer, 2010a; ten Berge et al., 2008a; Vermeulen
et al., 2010). However, whether and how this signaling pathway has its direct influence on
pluripotency gene networks and EMT events is largely unexplored.
As mentioned previously, cell fate decisions are controlled by both positive and negative forces
in human cells. It has been well-established that tumor suppressor genes (TSGs) are important
regulators to control cell proliferation, differentiation and cell death. Not surprisingly, these
genes also play important roles in programming, reprogramming, and stemness transition in
human cells. The well-studied TSGs, such as p53, p16, and RB1, serve as key regulators for the
cell programming (Bonizzi et al., 2012; Hong et al., 2009; Liu et al., 2009b; Marion et al., 2009;
Molchadsky et al., 2010; Wenzel et al., 2007). There are a number of reports on p53 / p21 pathway
that are involved in the reprogramming process and stemness transition in somatic cells. It
should be noted that Wnt signaling was linked to the p53 pathway a long time ago, suggesting
that both signaling pathways may play interactive and critical roles in cell fate determination
(Damalas et al., 1999; Kinzler and Vogelstein, 1996; Lee et al., 2010). Recent findings demon‐
strated that several mechanisms play a limiting role in somatic reprogramming and cell
stemness transition (Figure 1) (Kawamura et al., 2009; Menendez et al., 2012; Menendez et al.,
2010; Takahashi, 2010; Tapia and Scholer, 2010b). In most situations, these genes serve as active
players or barriers for cell reprogramming. However, many essential questions on the roles of
TSGs in cell fate decision remain unclear. For example, whether p53-induced inhibition in
reprogramming is transient or just in the early stage is still in question (Cox and Rizzino,
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2010; Krizhanovsky and Lowe, 2009; Wahl, 2011). Also, it was reported that the loss of RB1 is
critical for the expansion of the stem cell populations (Liu et al., 2009a; Wenzel et al., 2007).
Undoubtedly, there is an urgent need to further elucidate the molecular mechanism and
signaling pathways in regulating and controlling the process of somatic reprogramming and
stemness transition.
Epigenetic regulation is one of the important mechanisms in the regulation of TSG activities.
Recently, epigenetic modification has been shown to influence the reprogramming process,
suggesting that many known TSGs may be involved in these cellular activities. Some reports
illustrated that a dedifferentiation process of somatic cells to iPS cells involves dynamic
epigenetic remodeling. In addition, there seem to be interactions between reprogramming
transcription factors and epigenetic modifiers during these cellular activities (Takahashi, 2010).
In this chapter, the role of TSGs in cell reprogramming and stemness process, and regulation of
these genes during stem cell renewal will be discussed, as described in Figure 1. We will review
the role of TSG-mediated pathways and epigenetics as a barrier in cell fate determinations.
Figure 1. Schematic representative of somatic reprogramming. The reprogramming efficiency is markedly influence
by TSG-mediate pathways and epigenetic modifications.
1.1. CDKN2A (p16INK4A and p14ARF) gene
The CDKN2A (INK4/ARF) locus encodes two important TSGs, the p16INK4A (or p16) and p14ARF.
They are important regulators for two other critical tumor suppressive signaling pathways for
controlling cell proliferation, namely RB1 and p53. Utikal et al. reported that secondary murine
embryonic fibroblasts (MEFs) were capable of generating iPS cells at early passage, but the
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efficiency decreased after serial cell culture passaging and the concomitant onset of cellular
senescence (Utikal et al., 2009). This phenomenon was mainly correlated with accumulation
of molecular changes in the late passage senescent MEFs (Utikal et al., 2009). Indeed, up-
regulation of p16INK4A (INK4A), p14ARF (ARF), and p21CIP was concurrently observed in the late
passage of the MEFs (Utikal et al., 2009). Deficiency and knockdown of INK, ARF, and p53
expression resulted in higher efficiency of iPS cell formation. Interestingly, when MEFs were
cultured in low oxygen condition (4%), both the expression of INK4A and p53 were reduced.
Most importantly, the efficiency of the iPS reprogramming was increased in the low oxygen
condition. This further supports the role of CDKN2A and p53 in inhibiting the reprogramming
process (Utikal et al., 2009).
Concurrently, Li et al. also worked on the role of INK4/ARF locus which encodes three TSGs,
p16IN4A, p14ARF, and p15INK4B on the reprogramming of differentiated cell into iPS cells. They
showed that the locus is completely silenced in iPS and embryonic stem cells. The three
transcription factors, Oct4, Klf4, and Sox2 repressed the gene expression of p16INK4A, p14ARF,
and p15INK4B with concomitant appearance of iPS cells. In addition, genetic knockdown of the
INK4/ARF locus improved the efficiency of iPS cell generation. In mouse cells, ARF played
more significant role as compared to INK4A. In contrast, the INK4A function was more
prominent than the ARF in human cells (Li et al., 2009). Interestingly, ageing up-regulated the
gene expression of the three genes at the INK4/ARF locus and, in turn, led to less efficient
reprogramming in cells from old organisms; this defect can be rescued by genetically inhibiting
the INK4/ARF locus. Taken together, these findings provide strong evidence that supports the
role of CDKN2A in regulating cell reprogramming in iPS cells.
The epidermis is a tissue that undergoes continual and rapid self-renewal,  and which is
dependent on the presence of stem cells and transient amplifying keratinocytes. In primary
human keratinocytes, INK4A  also plays an important role in regulation of their stemness
properties  (Maurelli  et  al.,  2006).  The  INK4A  inactivation  enabled  the  primary  human
keratinocytes  to  escape  replicative  senescence  and  blocked  clonal  evolution  and  main‐
tained keratinocytes having the stemness phenotypes.  A persistent  INK4a  inactivation is
necessary for  maintenance of  immortalization of  the keratinocytes,  which was accompa‐
nied  by  reactivation  of  B  cell-specific  Moloney  murine  leukemia  virus  site  1  (Bmi-1)
expression and telomerase activity. Bmi-1 expression is necessary to maintain the immortal‐
ization induced by INK4a inactivation. In contrast, the INK4a inactivation in the transient
amplifying  keratinocytes  did  not  undergo  immortalization  but  senescence.  Thus,  INK4a
inactivation appears to selectively inhibit clonal conversion in highly proliferative somatic
cells. Interestingly, inactivation of INK4a up-regulated the ARF/p53/p21Waf1 pathway but this
up-regulation of the p53 pathway was unlikely to suppress the cell proliferation. The p53
pathway was necessarily inactivated during immortalization of human keratinocytes. This
study clearly  indicates  the  regulation  of  keratinocyte  clonal  evolution  by  INK4a  regula‐
tion and its inactivation in epidermal stem cells is necessary for maintaining the stemness
phenotypes (Maurelli et al., 2006).
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1.2. RB1 gene
RB1 (pRB1 family members: RB1, RBL1, and RBL2) was identified as a TSG in patients with
inherited retinoblastoma. It is one of the well-studied TSGs. It involves in cell cycle G1/S
transition regulation and binds to an important transcription factor family, E2F. Based on the
Knudson two-hit hypothesis, loss of single copy of pRB1 gene is not sufficient to induce tumor
formation, loss of another copy is necessary for inducing tumor formation (Knudson, 1971).
Mouse pRB1was found to be crucial during embryonic development; loss of two copies of RB1
gene in mouse embryo is lethal (Clarke et al., 1992; Jacks et al., 1992; Lee et al., 1992; Wu et al.,
2003). Trophoblasts are cells forming the outer layer of a blastocyst, which provide nutrients
to the embryo and develop into a large part of the placenta. Specific loss of mouse pRB1 gene
in trophoblast stem cells resulted in an overexpansion of trophoblasts, profound placental
abnormalities, and eventually fetal death (Wenzel et al., 2007). Loss of pRB1 resulted in an
increase of E2F3 expression and the combined depletion of pRB1 and E2F3 in trophoblast stem
cells rescued the pRB1 mutant phenotypes by restoration of placental development and by
extending the lifespan of embryos. As can be seen, the pRB1 pathway plays a critical role in
the maintenance of a mammalian stem cell population for proper development of both extra-
embryonic and fetal tissues.
Humans and other mammalians are unable to regenerate large portions of lost limbs or other
internal organs after traumatic injury or surgical excisions. In contrast, lower vertebrates are
able to regenerate entire limbs, the lens of the eye, and portions of the heart (Brockes and
Kumar, 2008; Poss et al., 2002; Tanaka and Weidinger, 2008). The difference can be explained
in part by the observation that inactivation of pRB1 alone in lower vertebrates was sufficient
to induce skeletal muscle regeneration by reversing differentiation and post-mitotic arrest in
the muscle cells (Tanaka et al., 1997). In mammalian muscle cells, suppression of pRB1 alone
was not sufficient to reverse the post-mitotic arrest and terminal differentiation (Camarda et
al., 2004; Huh et al., 2004; Pajcini et al., 2010). The tumor suppressor ARF which is present in
mammals, but absent in regenerative vertebrates, is a regeneration suppressor in addition to
pRB1 (Pajcini et al., 2010). Concurrent inactivation of both ARF and pRB1 resulted in mamma‐
lian muscle cell cycle re-entry cell proliferation and dedifferentiation (Pajcini et al., 2010). These
results indicate that suppression of both pRB1 and ARF will result in the ability of skeletal
muscle cells to lose their differentiated characters, and the skeletal muscle cells will then
proliferate and dedifferentiate in a manner that mimics the regenerative lower vertebrate cells.
Furthermore, pRB1 is not only restricted to serve as a cell cycle regulator, but also to impact
differentiation and tissue-specific gene expression directly by binding histone deacetylase 1
(HDAC1) and promoting activation of muscle genes such as the myogenic activator MyoD
(Puri et al., 2001).
The pRB1 gene family plays an important regulatory role in neuronal differentiation (Slack et
al., 1995). When treated with retinoic acid, the embryonal carcinoma p19 cells were induced
to differentiate into cultures primarily consisting of neurons and astrocytes. During this
neuroectodermal differentiation, a dramatically increase of pRB1 protein levels was observed.
When the pRB1 family proteins in the p19 cells were inactivated by the E1A mutant, the
differentiating p19 cells underwent apoptosis. The dying cells were those committed to the
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neural lineages because neurons and astrocytes were lost from the differentiating cell culture.
The results suggest that the pRB1 family proteins are essential for the neural lineage develop‐
ment and the absence of functional pRB1 activities will trigger cell death of the differentiating
neuroectodermal cells.
The pRB1 pathway is also critical for inducing the cellcycle arrest that mediates cell-cell contact
inhibition in fibroblasts; when all three pRB1 family members, RB1, RBL1, and RBL2, were
inactivated by triple knockouts (TKOs), the fibroblasts escaped from contact inhibition and
grew into 3D colonies or stacks in cell culture (Dannenberg et al., 2000; Sage et al., 2000). The
outgrowth of TKO MEFs into spheres triggered reprogramming to produce cells with cancer
stem cell properties. Whereas the fibroblasts with a single pRB1 mutation retained contact
inhibition, when this inhibition was bypassed by forcing the cells to form outgrowth spheres,
the fibroblasts were reprogrammed to generate cells with a cancer stem cell phenotype (Liu et
al., 2009a). These findings suggest a potential mechanism for generation of cancer stem cells
from differentiated somatic cells as a result of tumor outgrowth.
1.3. p53 gene
p53, as the “guardian of the genome” (Lane, 1992), plays a pivotal role in regulating the delicate
balance of cell proliferation and cell death (Molchadsky et al., 2010). Since its discovery more
than three decades ago, the role of p53 in suppressing tumor initiation and progression is well
established. It is, therefore, not surprising that p53 is lost, inactivated, or mutated in the
majority of cancers. In respond to external stress stimuli, p53 prevents cancer development by
inducing cellcycle arrest, DNA repair, senescence, and apoptosis.
Researchers have newly identified roles played by p53 including regulation of pluripotency
and dedifferentiation, as a potent barrier in reprogramming. (Hong et al., 2009). Undoubtedly,
the function of p53 is now far more complex than just simply playing the role as the classical
tumor suppressor (Bonizzi et al., 2012; Kawamura et al., 2009; Marion et al., 2009; Menendez
et al., 2010; Molchadsky et al., 2010; Tapia and Scholer, 2010a; Wahl, 2011; Zhao and Xu,
2010). This provides us with a new insight on the complexity of p53 signaling in controlling
cell fate decisions. Despite accumulating effort in deciphering the diversified roles played by
p53, the cellular and molecular mechanism underlying the acquisition of “stemness” involved
in the p53 signaling is still largely unexplored.
During somatic cell reprogramming, the p53 pathway is activated, thus disrupting iPS
reprogramming (Kawamura et al., 2009). p53 may act as a limiting factor in the iPS reprog‐
ramming efficiency. Inhibition of the p53 pathway either by mutating, deleting or knocking
down p53 or its target gene , p21, further enhances the reprogramming efficiency (Kawamura
et al., 2009; Liu et al., 2009b; Marion et al., 2009; Tapia and Scholer, 2010b).
The p53/p21 pathway was reported to suppress the iPS cell generation. Suppression of p53
increased the efficiency of the generation of iPS cells (Hong et al., 2009). A dominant negative
p53 mutant, P275S, was used to study the effect of p53 on regulating the iPS cell generation.
Results suggested that inhibition of p53 function by introducing the dominant negative p53
mutant into the MEFs increased GFP-positive colonies in the p53-heterozygous MEFs (Hong
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et al., 2009). Similar experiments were also performed in terminally differentiated somatic cells
(T-lymphocytes from Nanog-GFP reporter transgenic mice with either p53 wild-type or null
genotype). In this study, the four important stem cell reprogramming factors, Oct4, Sox2, Klf4,
and c-Myc were introduced into the T-lymphocytes. No GFP-positive colony can be observed
in the p53 wild-type T lymphocytes (Hong et al., 2009). On the other hand, GFP-positive
colonies can be observed in p53-null lymphocytes and the cells were expandable and have a
similar morphology with the mouse ES cells (Hong et al., 2009). The increased GFP-positive
cells can also be observed in the adult human dermal fibroblasts (HDFs) by introducing the
dominant negative p53 together with the reprogramming factors into the HDFs (Hong et al.,
2009), suggesting the importance of p53 in regulating the iPS cell reprogramming.
The function of p53 in regulating stem cell multipotency was confirmed in germ-line stem cells
(GSCs). Depletion of p53 function in the GSCs increased the efficiency of reverting GSC
multipotency status (Kanatsu-Shinohara et al., 2004). This finding can also be observed in a
p53 knockout mouse study (Lam and Nadeau, 2003). Hanna et al. suggested that depletion of
p53 function in clonal B cells can only enhance the kinetics of reprogramming somatic cells
into iPS cells with a higher cell division rate (Hanna et al., 2009). However, it does not regulate
the overall efficiency (Hanna et al., 2009). A p53 mutant, R172H, which induces conformation
change of the p53 protein, was reported to associate with higher reprogramming efficiency
than WT p53 in the MEFs (Lang et al., 2004). Lang et al. showed that reprogramming efficiency
in that particular p53-mutated MEFs, which was induced by utilizing a two factor system (Oct4
and Sox2), is higher than the p53 knockout MEFs that was induced by using the three factors
system (Oct4, Sox2, and Klf4) (Lang et al., 2004), suggesting the importance of p53 in regulating
the reprogramming process.
Cicalese et al. suggested that the function of p53 in stem cells is critical to maintain a constant
number of stem cells by imposing an asymmetric mode of self-renewing division. In the
p53-/- and ErbB2 tumor mammospheres, up-regulation of Nanog is observed. These studies
also revealed the importance of p53 in regulating the stem cell polarity, and the loss of p53
induces  increased  frequency  of  symmetric  division  and  tumor  initiation  and  growth
(Cicalese et al., 2009).
The suppression of the reprogramming efficiency of iPS cells by p53 can be associated with the
maintenance of genomic integrity of iPS cells. Deficient p53 resulted in shorter telomeres in
the reprogramming MEFs (Marion et al., 2009), suggesting the low efficiency of reprogram‐
ming in the WT p53 cells to prevent the spreading of cells upon DNA damage and to ensure
iPS cell genomic integrity (Marion et al., 2009).
Another barrier affecting the reprogramming is the INK4A/ARF tumor suppressor locus, as
described previously. A recent report by Li and colleagues illustrated that the INK4A/ARF
locus was suppressed during the early stage of reprogramming, leading to inactivation of the
p53 and pRB1 pathways (Li et al., 2009). Interestingly, cells with p16INK4A knockdown alone are
sufficient to enhance the reprogramming efficiency (Li et al., 2009). Together, these observa‐
tions indicate that both p53 and pRB1 may work synergistically as barriers in somatic cell
reprogramming (Li et al., 2009; Menendez et al., 2010; Utikal et al., 2009).
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In a recent report by Lee K.H. et al., p53 preferentially targets the Wnt signaling pathway in
the murine ESC differentiation program (Lee et al., 2010). Evidently, the crosstalk between p53
and Wnt signaling pathway plays an integrated role in stemness acquisition. A p53 down‐
stream phosphatase, Wip1, which shows high expression in the intestinal cells, was reported
to associate with p53-dependent apoptosis of stem cells in the mouse intestine (Demidov et al.,
2007). Removal of Wip1 reduced the polyp formation in the APCMin mice. The APCMin/+ mice
contain a nonsense mutation in the APC gene. Constitutively activated Wnt signaling pathway
increased the apoptosis events of intestinal stem cells in the Wip1-deficient mice (Demidov et
al., 2007). Low level of Wip1 reduced the threshold of p53-dependent apoptosis of stem cells.
However, Wip1 deficiency does not affect the activities of β-catenin in terms of its nuclear
localization level. A high level of β-catenin can be observed in the nuclei of polyp cells and
this contributes to up-regulation of c-Myc and Cyclin D1 in the Wip1 null/ApcMin/+mice. The β-
catenin signaling pathway activation and attenuation of p53 resulted in increasing efficiency
of intestinal stem cell apoptosis (Demidov et al., 2007).
Recently, researchers demonstrated that the p53-miR34-Wnt network is a determinant factor
of dichotomy between stem cell properties and tumor progression. miR34, one of the direct
downstream targets of p53, is found to interact with Wnt and EMT genes, including β-
catenin, AXIN2, LEF1 and Snail. With the loss of p53 due to miR34, the Wnt pathway is activated,
which further induced the transformation of EMT (Liu et al., 2011). Therefore, the p53 gene
plays an important role in the controlling EMT.
Chang et al suggested that p53 induced transcriptional activation of microRNA, miR-200c,
through direct binding to its promoter region. The miR-200c was reported to regulate the EMT
process through inhibition of transcriptional suppressors of an epithelial marker, E-cadherin
(Chang et al., 2011). The miR-200c can target to and suppress ZEB1/2 (Wellner et al., 2009),
which is a well-studied E-cadherin transcriptional suppressor and thus, regulates the EMT
process. The knockdown of p53 in MCF12A cells resulted in loss of epithelial phenotype and
shows a significant elevation of the CD24-CD44+ population. Re-expression of p53 in TGF-β-
treated MCF12A showed inhibition of TGF-β-induced increase of the stem cell population.
p53 is not a sole player in deciding the cell fate determination. In fact, p53 works as an integrated
network, interplaying with other important pathways, depending on the external stimuli and
microenviroment. However, there is a great need to further elucidate the roles of the p53
network in reprogramming, dedifferentiation, self-renewal, and pluripotency.
2. Signaling pathways involved in the reprogramming and stemness
transition
2.1. TGF–β signaling pathway
TGF-β signaling pathways play multiple roles in regulating tumorigenesis and other cellular
processes, including reprogramming, stemness transition, and EMT events. Many components
in this signaling pathway were defined to participate in both oncogenic and tumor suppressive
pathways in various tumors. This provides a complicated story for researchers to study the
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function of TGF-β signaling pathways in stem cells or reprogrammed cells. The ligands of the
TGF-β family have multiple functions and can cause opposite effects in different cell types.
The TGF-β can regulate cell proliferation, growth arrest, differentiation, survival, cell migra‐
tion, and also the pluripotency of cells. In cancer, over-expression of TGFβ1 and deregulation
of the TGF-β receptor type II (TGFBRII) were reported to associate with skin cancer tumori‐
genesis and invasiveness (Cui et al., 1996). However, the role of TGF-β signaling in regulating
reprogramming is still not well-defined. In a previous report, TGF-β family ligands play an
important role in reprogramming of somatic cells into iPS cells, regulating ESCs self-renewal,
pluripotency maintenance, and controlling differentiation.
TGF-β signalling may have the ability to induce reprogramming of somatic cells into iPS cells.
Treatment of TGF-β/activin inhibitor in partially reprogrammed iPS cells can induce Nanog
expression (Ichida et al., 2009; Maherali and Hochedlinger, 2009). Furthermore, the functional
role of TGF-β in regulating the reprogramming was defined by utilizing chemical TGF-β
inhibitors. Interestingly, inhibition of TGF-β signaling can enhance the mouse fibroblast
reprogramming efficiency. A substitute of Sox2 (E-616452) and TGFBR1 kinase (SB-431542)
inhibitor, were reported to replace the function of Sox2 in MEFs with Oct4, Klf4, and c-Myc
expression (Ichida et al., 2009; Maherali and Hochedlinger, 2009). These results suggest the
important roles TGF-β plays in the controlling reprogramming process.
Maintenance of the pluripotencies and self renewal properties are important for both ESCs
and iPS cells.The canonical TGF-β signaling pathway may play important regulatory roles in
ESCs maintenance and generation of pluripotency. BMP4 together with the LIF protein can
induce Oct4 expression (Ying et al., 2003). The BMP activated Smad signaling to support self-
renewal properties of stem cells. The inhibition of Smad activities by the Smad6 and Smad7 in
the ES cells induced smaller and fewer ES cell colon formation (Ying et al., 2003). Secretion of
BMP4 by the feeder cells is necessary for ES cell self-renewal (Ying et al., 2003). Inhibition of
the Erk and p38 MAPK pathways can further enhance the BMP4-associated effect on self-
renewal of mouse ESCs (Qi et al., 2004). Besides this, bFGF (basic fibroblast growth factor) and
activin are also important to maintain the pluripotency in human ESCs (Greber et al., 2010;
James et al., 2005). The TGF-β signalling may play multifunctional roles in regulating pluri‐
potency of cells. Smad1 was reported to suppress the expression of Nanog by inhibiting its
promoter activities (Jiang and Ng, 2008; Xu et al., 2008). The Smad proteins were reported to
bind directly to Nanog promoter (Xu et al., 2008) and this is the major mechanism for Smad
proteins to regulate Nanog expression. These results suggest the multiple roles of TGF-β
signaling in the regulation of stem cell renewal.
Furthermore, TGF-β also plays a role to control the differentiation of ESCs. One of the TGF-
β family members, BMP4, was reported to associate with induction of inhibitor of differentia‐
tion (Id) gene via interaction with the LIF/Jak-Stat3 and Smad pathways. The Id gene is an
important factor to block ESC differentiation. The undifferentiated ES cells expressed BMP
signaling ligands (Ying et al., 2003) and regulated downstream molecules, the Smads, to control
the cell differentiation process (Ying et al., 2003).
Collaborating with Wnt signaling, TGF-β signaling is also involved in the EMT program and
both pathways are regarded as the axis of EMT in breast cells (Scheel et al., 2011). The hy‐
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pothesis of these two pathways linked to the stem cell networks and TSG pathways is
presented in Figure 2.
2.2.Wnt pathway
Cellular reprogramming can be achieved by overexpression of defined transcription factors
in somatic cells (Ichida et al., 2009; Takahashi et al., 2007). However, the underlying mechanism
of signaling activities that regulated these factors are not fully understood now. Overexpres‐
sion for certain genes may not be suitable for all pathways, such as β-catenin, a mediator of
Wnt signaling, because discrete levels of expressed genes are usually needed for maintaining
the pluripotent status or direct programming through this pathway (Gu et al., 2010; Lluis et
al., 2008; Marson et al., 2008; Merrill, 2008). It still remains unclear the gene-dosage effects of
critical factors on somatic cell reprogramming and stem cell renewal. Recent studies revealed
that activation of Wnt/β-catenin signaling may directly control reprogramming of fused
somatic cells. For example, Wnt stimulators, Wnt3a and BIO, strikingly enhanced reprogram‐
ming ability after cell fusion (Lluis et al., 2008; Merrill, 2008). The fusion clones derived from
both ESCs and somatic cells had an obvious β-catenin accumulation with increased expression
of Axin2, a β-catenin-dependent gene, suggesting that basic or lower levels of stabilized β-
catenin might drive somatic cell reprogramming.
The lower levels of Wnt signaling play a critical role in the control of development of several
types of tissues through a dosage-dependent manner, as reported in crypt progenitor cells
(Batlle et al., 2002; Korinek et al., 1998), hair follicles (Lowry et al., 2005), and hematopoietic
stem cells (Luis et al., 2011). Taken together, observations from both in vitro and in vivo studies
indicated that Wnt/β-catenin signaling was a single dominant force in the control of cell fate
determinations in some of tissues, which suggests that basic or physiological levels of Wnt
signaling may be required for many cellular activities.
More and more evidence revealed that Wnt signaling plays important roles in maintenance of
pluripotency in ESCs and cell self-renewal (Cole et al., 2008; Lluis et al., 2008; Macarthur et al.,
2009; Marson et al., 2008; Takao et al., 2007). For example, expression of β-catenin was confirmed
Figure 2. The cell fate determination is delicately controlled by positive and negative forces. Cellular activity balance
regulated by both core stem gene-mediated pathways and TSGs is the key determinant in reprogramming process.
Future Aspects of Tumor Suppressor Gene84
to associate with hemtopoietic stem cells and neural stem cell growth (Kalani et al., 2008; Reya
et al., 2003). Wnt3A activation associated with expression of the stem cell reprogramming
markers, Oct4 and Nanog (Ogawa et al., 2007) and maintenance of the pluripotency of mouse
ES cells (Hao et al., 2006; Singla et al., 2006). Wnt3A induced generation of iPS cells in the
absence of Myc (Marson et al., 2008). Those cells contained iPS cell properties and were able
to form teratomas during subcutaneous injection into SCID mice (Marson et al., 2008). The Wnt
signaling pathway is also involved in regulating pluripotency factors, Oct4, Nanog, and Sox2
expression (Anton et al., 2007; Sato et al., 2004). This observation was confirmed by down-
regulation of the stem cell pluripotency genes in the β-catenin deficient mouse ES cells (Anton
et al., 2007). Wnt signaling pathway was also associated with cell reprogramming through the
telomerase reverse transcriptase (TERT) and Brahma-related gene 1 (BRG1) interaction (Barker
et al., 2001) to modulate chromatin structure during reprogramming (Miki et al., 2011).
Interestingly, previous study demonstrated that Wnt3a can also stimulate human ES cell
differentiation, rather than only regulate human ES cell proliferation. The canonical Wnt
signaling levels are minimal in the undifferentiated human ES cells but greatly increase after
Wnt3a treatment and induce differentiation (Dravid et al., 2005). Dramatic increase of reprog‐
rammed cell numbers can be observed when ES cells, which have a low level of nuclear β-
catenin, are fused with neural stem cells. This is mainly due to the low nuclear β-catenin level
being able to protect fused cells from apoptosis (Lluis et al., 2010), suggests the importance of
β-catenin levels in the regulation of stem cell reprogramming. This finding may help to explain
the balance between the maintenance of pluripotency of stem cells and apoptosis, as excess
β-catenin can induce p53 expression (Damalas et al., 1999), which was found to induce
apoptosis in stem cells to maintain genome integrity. The p53 protein was reported to be a
transcription regulator of the Wnt signaling and it bound on the promoter regions of some
Wnt signaling members for a general stress response in the mouse ES cells (Lee et al., 2010),
which may provide a feedback mechanism to control the deregulation of the β-catenin during
the reprogramming process.
It should be noted that inappropriate activation of components of this signaling pathway have
been observed in many human cancers and differentiated stem cells, in which the high levels
of β-catenin signaling were usually detected (Dravid et al., 2005; Fodde and Brabletz, 2007; ten
Berge et al., 2008a; Vermeulen et al., 2010). Except for p53 described previously, some compo‐
nents of the Wnt pathway can be regarded as both oncogenes and TSGs. For example, AXIN2,
APC, DKK1, and WIF1 are negative regulators of this pathway, and are called TSGs. In
summary, the detailed mechanism of Wnt signaling in the control of stemness transition and
reprogramming of somatic cells needs to be further explored.
3. Possible mechanisms to regulate TSGs expression in reprogramming
It is well-accepted now that epigenetic regulations are important events to control gene
expression in human cells. Promoter hypermethylation and histone modification are two major
events to regulate gene expression in various human tumors. The DNA methyltransferase
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(DNMTs), histone deacetylases (HDACs), histone acetyl transferase (HATs), and histone methyl‐
transferase are the key regulators to controlgene expression in the genome. Epigenetic changes
of gene expression were reported to be important during the iPS cell reprogramming (Han
and Sidhu, 2008). The epigenetic changes can also help to maintain the pluripotency by
regulating the expression of the key transcription factors, Oct4, Nanog, and Sox2 (van Vlerken
et al., 2012). In previous studies, mouse ES cell genomes were found to contain less methylation
than the somatic cells, while human ES cells show a distinct epigenetic profile, when compared
to somatic cells (Jackson et al., 2004; Lagarkova et al., 2006; Zvetkova et al., 2005). A silenced
TSG, p16, was found to be re-expressed during the reprogramming process (Ron-Bigger et al.,
2010). On the other hand, a previous study suggested that the promoter region of INK4A/ARF
was found to be hypermethylated in the iPS and ES cells. Inhibition of DNMTs by inhibitor
and siRNA increased the INK4A and p21 (CIP1/WAF1) expression in human umbilical cord
blood-derived multipotent stem cells (So et al., 2011). However, the epigenetic regulation of
TSGs during the reprogramming process is still not fully understood now. It is necessary to
further explore epigenetic changes of TSGs in the reprogramming process and relevant other
cellular activities.
Figure 3. Hypothesis of integrated networks of TGSs, Wnt/β-catenin and TGF-β pathways in controlling reprogram‐
ming, stemness transition and EMT events. These pathways may play central roles in regulating other TSGs, transcrip‐
tional factors and other signaling pathways.
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4. Conclusions
The known and unknown TSGs are the important participators in the regulation of cell
reprogramming and stemness transition. These genes are components of various signaling
pathways, and play different roles in maintaining cell pluripotency, regulating cell differen‐
tiation and proliferation, cell cycle control, apoptosis, and other cell fate decisions. These genes
controlling cellular activities act in a time-dependent or a dosage-dependent manner in various
tissues. Although detailed underlying mechanisms are not fully clear now, more and more
evidence indicates that some TSG signaling activities are determinant forces in important
cellular processes, including cell reprogramming. A proposed hypothesis illustrates this in
Figure 3. Understanding of the delicate control of these signaling networks in living cells will
provide more insight in reprogramming studies and regenerative medicine.
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